ArticleLiver international : official journal of the International Association for the Study of the Liver2022
Is ageing a problematic hurdle to the efficacy of first-line atezolizumab plus bevacizumab in hepatocellular carcinoma?
Jihyun An et al.PubMed ↗Publisher ↗
No numbers read from the abstract.